Potassium Chloride Tablet, Film Coated, Extended Release
Product Images NDC 33342-418

This is a product description for Macleods Pharma USA's Potassium Chloride Extended-Release Tablets, USP. Each pack contains 70 unit-dose tablets with 8 mEq (600 mg) of potassium chloride. The tablets are manufactured in India by Macleods Pharmaceuticals Ltd. and distributed by Macl Inc. The tablets are intended for oral use and should be stored at 68-77°F. The packaging is not child-resistant, so it's important to keep the tablets out of reach of children.*

This is a description for Macleods Pharm USA's Potassium Chloride Extended-Release Tablets, USP with 10 mEq (750 mg) potency. It comes in a unit-dose package with 70 tablets, each containing potassium equivalent to 10 mEq. Manufactured in India and distributed in the USA, the tablets should be stored at 20-26°C and protected from light and moisture. The dosage should be adjusted as per individual patient needs. It is not child-resistant and should be kept out of children's reach. For more detailed information on usage, refer to the package insert or consult a healthcare provider.*

This is a description of Macleods Pharma USA's Potassium Chloride Extended-Release Tablets, USP containing 8 mEq (600 mg) of potassium. The tablets are FDA approved, and dosages should be adjusted to meet individual patient needs. They should be stored at 20° to 25°C (68° to 77°F) with permitted excursions to 15° to 30°C (59° to 86°F), protected from light and moisture. The tablets should be dispensed in a tightly closed container with a child-resistant closure. The manufacturer is Macleods Pharmaceuticals Ltd. in India, with distribution by Macleods Pharma USA, Inc. in Princeton, NJ. Patients are advised that the tablet's extended-release matrix may not be absorbed and could be excreted intact in the stool.*

This text provides information about extended-release Potassium Chloride tablets, each containing 600 mg (equivalent to potassium 8 mEq). It includes FDA-approved acceptance criteria, dosage instructions, storage recommendations, and manufacturer details. Patients are advised that the extended matrix may not be absorbed and could pass intact in stool. The tablets should be kept out of reach of children and stored in a tightly closed container away from light and moisture.*

A description for the provided text is: This is a medication label for "Potassium Chloride Extended-Release Tablets". Each tablet contains 750 mg of Potassium Chloride equivalent to 10 mEq of potassium. The usual dosage and storage instructions are included. The product is manufactured by Macleods Pharmaceuticals and distributed by Macleods Pharma USA, Inc. The label also provides information regarding FDA approval criteria, dosing adjustments, storage conditions, and a caution to be aware that the extended-release matrix may not be absorbed and could be excreted in stool.*

This text provides information on a medication called Potassium Chloride in 750 mg extended-release tablets, with each tablet being equivalent to 10 mEq of potassium. It includes details on dosage adjustment based on individual patient needs, storage conditions (20° to 25°C), and precautions against light and moisture exposure. The text also mentions FDA approved criteria, labeling requirements, and the manufacturer Macleods Pharma USA, Inc. It ends with a note advising patients that the medication may pass through the body without being absorbed and should be kept away from children.*